首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   22154篇
  免费   1374篇
  国内免费   742篇
耳鼻咽喉   41篇
儿科学   459篇
妇产科学   211篇
基础医学   5373篇
口腔科学   251篇
临床医学   2234篇
内科学   3789篇
皮肤病学   438篇
神经病学   1121篇
特种医学   416篇
外国民族医学   3篇
外科学   1383篇
综合类   3381篇
现状与发展   5篇
预防医学   1695篇
眼科学   155篇
药学   1632篇
  8篇
中国医学   232篇
肿瘤学   1443篇
  2024年   27篇
  2023年   260篇
  2022年   620篇
  2021年   729篇
  2020年   587篇
  2019年   573篇
  2018年   543篇
  2017年   559篇
  2016年   598篇
  2015年   627篇
  2014年   965篇
  2013年   1385篇
  2012年   977篇
  2011年   1115篇
  2010年   822篇
  2009年   839篇
  2008年   848篇
  2007年   947篇
  2006年   837篇
  2005年   850篇
  2004年   786篇
  2003年   753篇
  2002年   627篇
  2001年   573篇
  2000年   563篇
  1999年   452篇
  1998年   474篇
  1997年   489篇
  1996年   440篇
  1995年   517篇
  1994年   475篇
  1993年   431篇
  1992年   413篇
  1991年   400篇
  1990年   335篇
  1989年   235篇
  1988年   254篇
  1987年   204篇
  1986年   162篇
  1985年   316篇
  1984年   207篇
  1983年   144篇
  1982年   95篇
  1981年   68篇
  1980年   37篇
  1979年   32篇
  1978年   31篇
  1977年   13篇
  1976年   9篇
  1974年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Administration of antiserum to thyrotropin-releasing hormone (TRH) into the lateral cerebral ventricle of mice significantly attenuated recovery from hyperglycemia induced by treatment with 2-deoxyglucose but had no effect on the plasma glucose of saline-treated mice. TRH, injected centrally together with the anti-TRH antibody, reversed the effect of the antiserum and blocked the development of hyperglycemia. These findings suggest that activation of TRH neurons in the central nervous system may be a physiological event influencing recovery from hyperglycemia.  相似文献   
72.
Mice immunized against anti-substance P (anti-SP) monoclonal antibodies produced anti-SP anti-idiotypic antibodies (SPAb2). In a previous report. SPAb2 antibodies were found to have in vitro biological activity i.e. to behave either as agonists or as antagonists for substance P (SP) depending on the biological test. In this study, the involvement of SPAb2 in vivo biological activity has been tested. Because of the possible implication of SP in the generation and transmission of nociceptive information, we have tested the responsiveness of SPAb2 responding mice in behavioral nociceptive tests. SPAb2 mice showed very small behavioral variations in the hot plate test as compared with a control group of mice immunized against an unrelated monoclonal antibody. In the formalin test, however, SPAb2 mice displayed a significant increase in paw licking time, which was significantly correleted with SPAb2 serum concentration. These results are discussed in terms of the use of SPAb2 as pharmacological tools for studying the biological properties of SP receptors and more generally of auto anti-idiotypic antibodies in modulating behavior responses.  相似文献   
73.
目的分离、培养和鉴定正常人肾小球系膜细胞。方法筛网滤过分离正常人肾小球系膜细胞,同时采用免疫荧光技术,利用异硫氰酸荧光素(FITC)间接标记单克隆抗体:抗Ⅷ因子相关抗原抗体、抗结蛋白抗体、抗角蛋白抗体、抗细胞角蛋白抗体、抗Ⅳ型胶原抗体、抗纤维连接蛋白抗体、抗层粘连蛋白抗体对系膜细胞特有的中间微丝进行鉴定。并采用同期培养的同一来源的肾小球内皮细胞作对照。结果抗Ⅷ因子相关抗原、抗角蛋白和抗细胞角蛋白抗体表达均为阴性,而抗结蛋白抗体、抗Ⅳ型胶原抗体、抗纤维连接蛋白抗体、抗层粘连蛋白抗体为阳性,说明培养的细胞为系膜细胞。结论该种方法分离培养的细胞经过免疫荧光染色鉴定为肾小球系膜细胞。  相似文献   
74.
Longitudinal studies were conducted over a five-year period for HLA antibodies on 493 sera tested from 54 kidney transplant patients. HLA single antigen beads were employed to establish donor specificity of the antibodies. Only 3 of 22 patients without antibodies rejected a graft in contrast to 17 out of 32 patients with posttransplant antibodies (p = 0.003). Using a serum creatinine value of 4.0 mg/dL as the cut-off for a failed graft, 4 of 22 patients without antibodies failed compared to 21 of 32 with antibodies (p = 0.0006). Among patients with donor-specific antibodies (DSA) 13 of 15 failed (p = 0.000004). Even among patients with non-donor specific antibodies (NDSA), 8 of 17 failed (p = 0.05). Among patients who could be identified as making de novo antibodies (since they developed antibodies while not having antibodies for more than six months after transplantation), 6 of 11 failed (p = 0.03). Sequential testing for HLA antibodies shows that antibodies appear prior to a rise in serum creatinine and subsequent graft failure. The very strong association between the production of HLA antibodies after transplantation and graft failure indicates the importance of monitoring for posttransplant HLA antibodies.  相似文献   
75.
目的:为研究人类新月体抗肾炎的发病机制,建立大鼠抗肾小球基底膜(BGM)肾炎的动物模型,方法:提取S-D大鼠GBM抗原,将此抗原免疫新西兰白兔获得抗血清,再将此抗血清从尾静脉一次性注射给S-D大鼠。实验分2组:肾炎模型组及正常对照组。定期于第4天、第14天第第21天检测大鼠24h尿蛋白,血肌酐及血尿素的含量和肾组织病理学改变。结果:大鼠肾炎模型组:大鼠注射抗血清后于第4天出现大量蛋白尿,第14天血肌酐,血尿素显著升高,并持续上升,肾组织病理表现为肾小球内细胞数明显增加,大量新月体形成及蛋白管型,GBM呈不规则增厚,足突融合,内皮细胞脱落,坏死,免疫荧光检查见IgG、鼠IgG沿GBM线形分布,大鼠正常对照组以上指标均无明显改变。结论:通过动态观察大鼠抗GBM肾炎的病变变化,证实该模型病变与人类新月体性肾炎的病变较为一致,该模型可用于探讨人类新月体体肾炎的实验研究。  相似文献   
76.
单克隆抗体对溶组织内阿米巴吞噬红细胞的影响   总被引:1,自引:0,他引:1  
用具有抗细胞膜活性和抗细胞核、胞浆活性的单克隆抗体3F7和4G6与致病性溶组织内阿米巴HM-1∶IMSS株滋养体37℃孵育,在孵育即刻、5min、10min加入红细胞,检测滋养体吞噬红细胞的能力,并以正常小鼠血清和抗克氏锥虫抗体TCE04作为对照。结果,经单克隆抗体3F7孵育即刻的HM-1∶IMSS虫株滋养体吞噬红细胞能力明显减弱(P<0.001),而4G6抑制滋养体吞噬红细胞的作用不如前者明显。提示,抗细胞膜单克隆抗体对抑制滋养体吞噬红细胞有显著作用,但随着时间的推移,抑制作用明显减弱。  相似文献   
77.
Both mice and rabbits immunized with dengue virus E protein peptide spanning amino acids 100–119 (D4E) produced antibodies that reacted not only with the D4E peptide itself but also with human plasminogen, as shown by ELISA and Western blot. Sera from dengue virus-hyperimmunized mice and dengue patients also contained antibodies against D4E and plasminogen. Furthermore, such sera all contained plasmin inhibitory activity. Using affinity-purified anti-D4E antibodies and free D4E peptide for competitive inhibition, we demonstrated that the inhibition of plasmin activity was due to anti-D4E antibodies rather than other substances in the sera. Taken together, these results suggest dengue virus E protein amino acids 100–119 are a cross-reactive immunogenic region, and antibodies against this region may interfere with human fibrinolysis.  相似文献   
78.
对硫磷人工抗原合成及其鉴定   总被引:3,自引:0,他引:3  
目的 制备对硫磷人工抗原和抗血清,为建立酶联免疫吸附法提供技术储备。方法 还原对硫磷硝基成为氨基,合成半抗原氨基对硫磷;重氮化偶联大分子载体牛血清白蛋白制备人工抗原;免疫新西兰白兔。进行多抗制备。结果 合成的半抗原核磁共振图谱鉴定结果为6:6.9~7(m,2H,CH2)6.4~6.5(m,2H,CH2)4.1~4.2(q,4H-CH2)3.4(s,2H,NH2)1.3~1.4(t,6H,CH3);氨基对硫磷与牛血清白蛋白的结合比为35~36:1;抗血清经间接酶联免疫吸附法检测,效价达1:128000,双向免疫扩散实验测得抗血清与人工抗原形成沉淀;间接竞争酶联免疫吸附法测得抗血清对对硫磷最低抑制浓度为0.16ng/mL;经间接酶联免疫吸附法检测人工抗原与羊抗人血清、兔抗人血清、正常兔血清无交叉反应。结论 合成对硫磷半抗原及人工抗原纯度高、结合比高。具有较好的免疫原性。  相似文献   
79.
应用抗猪囊虫抗原的单克隆抗体反向间接血凝试验(IHAT),对临床确诊的囊虫病患者进行了血清循环抗原(CAg)的检测,阳性率为51.14%(67/131)。对19例脑型囊虫病患者同时测定了血清和脑脊液中的CAg,阳性率分别为47.36%和78.94%,总阳性率为84.21%。对治疗0.53后的19例患者检测时,血清和脑脊液中CAg均呈阴性反应,而检测抗体仍呈阳性反应。50例正常人、49例其它寄生虫病及5例其它脑部疾病患者脑脊液的CAg均呈阴性反应。结果提示:测定CAg对囊虫病活动性感染的诊断及疗效判定均具有一定的实用价值。  相似文献   
80.
Vaccination of mice with attenuated S. japonicum cercariae induces protection against secondary infection which can be transferred to naive mice with serum (VMS). The presence of antibody does not per se impart protection as serum from mice carrying non-attenuated infections (CIS), contains high levels of specific antibody, but confers no protection. Here we describe the increased protection transferred (20 to 68%) with increased number of vaccinations (one to five) given to the donors, and its decline with time after the final vaccination. We also describe the development of IgM, IgA, IgE, total IgG and IgG subclass responses in VMS, giving different levels of protection and CIS, directed against sodium periodate-sensitive and -resistant epitopes in ‘skin-stage’, ‘lung-stage’and ‘liver-stage’schistosomula, adult worms and eggs. In addition, antibody affinity maturation, development of S. japonicum species-specific responses, and vaccination-specific responses were examined. No response developed in parallel with serum-mediated immunity, suggesting immunity may be due to responses against individual antigens. Preliminary examination of antigens recognized in Western blot showed that two schistosomal membrane antigens, of 13 and 40 kDa, were recognized by VMS from mice vaccinated five times (68% protection), but not by twice vaccinated VMS (27% protection). Neither antigen was recognized by non-protective CIS.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号